Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.8.1.4 (
diaphorase
)
2,754
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Bactericidal/permeability-increasing protein [
BPI
] is a cationic antimicrobial protein from neutrophils that specifically binds to the surfaces of Gram-negative bacteria via the lipid A component of lipopolysaccharide. To obtain information about the responses of Salmonella typhimurium to cell-surface damage by
BPI
, two-dimensional gel electrophoresis and N-terminal microsequencing were used to identify proteins that were induced or repressed following
BPI
treatment. The majority of the affected proteins are involved in central metabolic processes. Upon addition of
BPI
, the beta-subunit of the F1 portion of Escherichia coli ATP synthase was repressed threefold whereas six proteins were induced up to 11-fold. Three of the latter were identified as
lipoamide dehydrogenase
, enoyl-acyl carrier protein reductase, and the heat-shock protein HtpG. Additionally, a novel protein, BipA, was identified that is induced over sevenfold by
BPI
; sequence analysis suggests that it belongs to the GTPase superfamily and interacts with ribosomes. A conserved direct-repeat motif is present in the regulatory regions of several
BPI
-inducible genes, including the bipA gene. Only one of the
BPI
-responsive proteins was induced when cells were treated with polymyxin B, which also binds to lipid A. We therefore conclude that
BPI
and polymyxin B affect different global regulatory networks in S. typhimurium even though they bind with high affinity to the same cell-surface component.
...
PMID:Salmonella typhimurium responses to a bactericidal protein from human neutrophils. 855 71